nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Estradiol—osteoporosis	0.467	1	CbGbCtD
Dolutegravir—POU2F2—BCR signaling pathway—NFATC1—osteoporosis	0.00725	0.171	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—VDR—osteoporosis	0.00557	0.131	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.00413	0.0973	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—NFATC1—osteoporosis	0.00407	0.0957	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—WNT1—osteoporosis	0.00389	0.0915	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00388	0.0913	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.00269	0.0633	CbGpPWpGaD
Dolutegravir—Mental disorder—Estropipate—osteoporosis	0.00194	0.00395	CcSEcCtD
Dolutegravir—Immune system disorder—Ibandronate—osteoporosis	0.00192	0.00391	CcSEcCtD
Dolutegravir—Flatulence—Estropipate—osteoporosis	0.0019	0.00387	CcSEcCtD
Dolutegravir—Diarrhoea—Calcium Acetate—osteoporosis	0.00189	0.00386	CcSEcCtD
Dolutegravir—Flatulence—Alendronate—osteoporosis	0.00187	0.00381	CcSEcCtD
Dolutegravir—Mental disorder—Ibandronate—osteoporosis	0.00186	0.00379	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Risedronate—osteoporosis	0.00184	0.00375	CcSEcCtD
Dolutegravir—Flatulence—Raloxifene—osteoporosis	0.00184	0.00375	CcSEcCtD
Dolutegravir—Dizziness—Calcium Acetate—osteoporosis	0.00183	0.00373	CcSEcCtD
Dolutegravir—Renal failure—Pamidronate—osteoporosis	0.00182	0.00371	CcSEcCtD
Dolutegravir—Flatulence—Ibandronate—osteoporosis	0.00182	0.00371	CcSEcCtD
Dolutegravir—Abdominal discomfort—Zoledronate—osteoporosis	0.00182	0.00371	CcSEcCtD
Dolutegravir—Neutropenia—Zoledronate—osteoporosis	0.00177	0.00362	CcSEcCtD
Dolutegravir—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.00177	0.00361	CcSEcCtD
Dolutegravir—Vomiting—Calcium Acetate—osteoporosis	0.00176	0.00359	CcSEcCtD
Dolutegravir—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.00176	0.00358	CcSEcCtD
Dolutegravir—Asthenia—Ergocalciferol—osteoporosis	0.00175	0.00358	CcSEcCtD
Dolutegravir—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00175	0.00357	CcSEcCtD
Dolutegravir—Vertigo—Estropipate—osteoporosis	0.00173	0.00353	CcSEcCtD
Dolutegravir—Urinary tract disorder—Risedronate—osteoporosis	0.00173	0.00352	CcSEcCtD
Dolutegravir—Urethral disorder—Risedronate—osteoporosis	0.00171	0.00349	CcSEcCtD
Dolutegravir—Vertigo—Alendronate—osteoporosis	0.0017	0.00347	CcSEcCtD
Dolutegravir—Vertigo—Raloxifene—osteoporosis	0.00168	0.00342	CcSEcCtD
Dolutegravir—Renal failure—Zoledronate—osteoporosis	0.00166	0.00339	CcSEcCtD
Dolutegravir—Vertigo—Ibandronate—osteoporosis	0.00166	0.00338	CcSEcCtD
Dolutegravir—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00165	0.00336	CcSEcCtD
Dolutegravir—Nausea—Calcium Acetate—osteoporosis	0.00164	0.00335	CcSEcCtD
Dolutegravir—Urinary tract disorder—Pamidronate—osteoporosis	0.00164	0.00335	CcSEcCtD
Dolutegravir—Urethral disorder—Pamidronate—osteoporosis	0.00163	0.00332	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00163	0.00332	CcSEcCtD
Dolutegravir—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00162	0.0033	CcSEcCtD
Dolutegravir—Renal failure—Conjugated Estrogens—osteoporosis	0.0016	0.00326	CcSEcCtD
Dolutegravir—Immune system disorder—Risedronate—osteoporosis	0.00158	0.00322	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00158	0.00322	CcSEcCtD
Dolutegravir—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00157	0.0032	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00156	0.00318	CcSEcCtD
Dolutegravir—Abdominal pain upper—Estradiol—osteoporosis	0.00155	0.00315	CcSEcCtD
Dolutegravir—Nervous system disorder—Estropipate—osteoporosis	0.00154	0.00314	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00154	0.00314	CcSEcCtD
Dolutegravir—Mental disorder—Risedronate—osteoporosis	0.00153	0.00312	CcSEcCtD
Dolutegravir—Skin disorder—Estropipate—osteoporosis	0.00153	0.00311	CcSEcCtD
Dolutegravir—Immune system disorder—Pamidronate—osteoporosis	0.0015	0.00306	CcSEcCtD
Dolutegravir—Flatulence—Risedronate—osteoporosis	0.0015	0.00306	CcSEcCtD
Dolutegravir—Urinary tract disorder—Zoledronate—osteoporosis	0.0015	0.00306	CcSEcCtD
Dolutegravir—Nervous system disorder—Raloxifene—osteoporosis	0.00149	0.00304	CcSEcCtD
Dolutegravir—Alanine aminotransferase increased—Estradiol—osteoporosis	0.00149	0.00304	CcSEcCtD
Dolutegravir—Urethral disorder—Zoledronate—osteoporosis	0.00149	0.00303	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00149	0.00303	CcSEcCtD
Dolutegravir—Skin disorder—Raloxifene—osteoporosis	0.00148	0.00301	CcSEcCtD
Dolutegravir—Nervous system disorder—Ibandronate—osteoporosis	0.00148	0.00301	CcSEcCtD
Dolutegravir—Skin disorder—Ibandronate—osteoporosis	0.00146	0.00298	CcSEcCtD
Dolutegravir—Nausea—Ergocalciferol—osteoporosis	0.00145	0.00296	CcSEcCtD
Dolutegravir—Abdominal pain—Etidronic acid—osteoporosis	0.00144	0.00293	CcSEcCtD
Dolutegravir—Skin disorder—Calcitriol—osteoporosis	0.00143	0.00292	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.00143	0.0337	CbGpPWpGaD
Dolutegravir—Insomnia—Estropipate—osteoporosis	0.00142	0.0029	CcSEcCtD
Dolutegravir—Abdominal discomfort—Estradiol—osteoporosis	0.0014	0.00286	CcSEcCtD
Dolutegravir—Insomnia—Raloxifene—osteoporosis	0.00138	0.00281	CcSEcCtD
Dolutegravir—Immune system disorder—Zoledronate—osteoporosis	0.00137	0.0028	CcSEcCtD
Dolutegravir—Vertigo—Risedronate—osteoporosis	0.00137	0.00279	CcSEcCtD
Dolutegravir—Insomnia—Ibandronate—osteoporosis	0.00136	0.00278	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Estropipate—osteoporosis	0.00136	0.00277	CcSEcCtD
Dolutegravir—Fatigue—Estropipate—osteoporosis	0.00136	0.00276	CcSEcCtD
Dolutegravir—Hypersensitivity—Etidronic acid—osteoporosis	0.00134	0.00273	CcSEcCtD
Dolutegravir—Insomnia—Calcitriol—osteoporosis	0.00134	0.00272	CcSEcCtD
Dolutegravir—Mental disorder—Zoledronate—osteoporosis	0.00133	0.00271	CcSEcCtD
Dolutegravir—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00132	0.00269	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00132	0.00269	CcSEcCtD
Dolutegravir—Hyperglycaemia—Estradiol—osteoporosis	0.00132	0.00269	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00132	0.00268	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Ibandronate—osteoporosis	0.0013	0.00265	CcSEcCtD
Dolutegravir—Fatigue—Ibandronate—osteoporosis	0.0013	0.00265	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00129	0.00262	CcSEcCtD
Dolutegravir—Pruritus—Etidronic acid—osteoporosis	0.00129	0.00262	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Estropipate—osteoporosis	0.00129	0.00262	CcSEcCtD
Dolutegravir—Mental disorder—Conjugated Estrogens—osteoporosis	0.00128	0.00261	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Alendronate—osteoporosis	0.00127	0.00258	CcSEcCtD
Dolutegravir—Flatulence—Conjugated Estrogens—osteoporosis	0.00125	0.00256	CcSEcCtD
Dolutegravir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00125	0.00255	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Raloxifene—osteoporosis	0.00125	0.00254	CcSEcCtD
Dolutegravir—Diarrhoea—Etidronic acid—osteoporosis	0.00124	0.00253	CcSEcCtD
Dolutegravir—Abdominal pain—Estropipate—osteoporosis	0.00124	0.00253	CcSEcCtD
Dolutegravir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00124	0.00252	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Estradiol—osteoporosis	0.00123	0.00251	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Ibandronate—osteoporosis	0.00123	0.00251	CcSEcCtD
Dolutegravir—Abdominal pain—Alendronate—osteoporosis	0.00122	0.00249	CcSEcCtD
Dolutegravir—Nervous system disorder—Risedronate—osteoporosis	0.00122	0.00248	CcSEcCtD
Dolutegravir—Skin disorder—Risedronate—osteoporosis	0.00121	0.00246	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Calcitriol—osteoporosis	0.00121	0.00246	CcSEcCtD
Dolutegravir—Abdominal pain—Raloxifene—osteoporosis	0.0012	0.00245	CcSEcCtD
Dolutegravir—Abdominal pain—Ibandronate—osteoporosis	0.00119	0.00243	CcSEcCtD
Dolutegravir—Vertigo—Zoledronate—osteoporosis	0.00119	0.00242	CcSEcCtD
Dolutegravir—Hepatitis—Estradiol—osteoporosis	0.00117	0.00238	CcSEcCtD
Dolutegravir—Abdominal pain—Calcitriol—osteoporosis	0.00117	0.00238	CcSEcCtD
Dolutegravir—Hypersensitivity—Estropipate—osteoporosis	0.00116	0.00236	CcSEcCtD
Dolutegravir—Nervous system disorder—Pamidronate—osteoporosis	0.00116	0.00236	CcSEcCtD
Dolutegravir—Urinary tract disorder—Estradiol—osteoporosis	0.00116	0.00236	CcSEcCtD
Dolutegravir—Vomiting—Etidronic acid—osteoporosis	0.00116	0.00235	CcSEcCtD
Dolutegravir—Urethral disorder—Estradiol—osteoporosis	0.00115	0.00234	CcSEcCtD
Dolutegravir—Rash—Etidronic acid—osteoporosis	0.00115	0.00234	CcSEcCtD
Dolutegravir—Dermatitis—Etidronic acid—osteoporosis	0.00114	0.00233	CcSEcCtD
Dolutegravir—Vertigo—Conjugated Estrogens—osteoporosis	0.00114	0.00233	CcSEcCtD
Dolutegravir—Hypersensitivity—Alendronate—osteoporosis	0.00114	0.00232	CcSEcCtD
Dolutegravir—Headache—Etidronic acid—osteoporosis	0.00114	0.00232	CcSEcCtD
Dolutegravir—Asthenia—Estropipate—osteoporosis	0.00113	0.0023	CcSEcCtD
Dolutegravir—Insomnia—Risedronate—osteoporosis	0.00112	0.00229	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00112	0.00228	CcSEcCtD
Dolutegravir—Pruritus—Estropipate—osteoporosis	0.00111	0.00227	CcSEcCtD
Dolutegravir—Asthenia—Alendronate—osteoporosis	0.00111	0.00226	CcSEcCtD
Dolutegravir—Hypersensitivity—Ibandronate—osteoporosis	0.00111	0.00226	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0011	0.00224	CcSEcCtD
Dolutegravir—Fatigue—Ethinyl Estradiol—osteoporosis	0.0011	0.00224	CcSEcCtD
Dolutegravir—Pruritus—Alendronate—osteoporosis	0.0011	0.00223	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.00109	0.0256	CbGpPWpGaD
Dolutegravir—Hypersensitivity—Calcitriol—osteoporosis	0.00109	0.00222	CcSEcCtD
Dolutegravir—Asthenia—Ibandronate—osteoporosis	0.00108	0.0022	CcSEcCtD
Dolutegravir—Nausea—Etidronic acid—osteoporosis	0.00108	0.0022	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00108	0.00219	CcSEcCtD
Dolutegravir—Diarrhoea—Estropipate—osteoporosis	0.00108	0.00219	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Risedronate—osteoporosis	0.00107	0.00219	CcSEcCtD
Dolutegravir—Fatigue—Risedronate—osteoporosis	0.00107	0.00218	CcSEcCtD
Dolutegravir—Insomnia—Pamidronate—osteoporosis	0.00107	0.00218	CcSEcCtD
Dolutegravir—Pruritus—Ibandronate—osteoporosis	0.00107	0.00217	CcSEcCtD
Dolutegravir—Diarrhoea—Alendronate—osteoporosis	0.00106	0.00216	CcSEcCtD
Dolutegravir—Asthenia—Calcitriol—osteoporosis	0.00106	0.00216	CcSEcCtD
Dolutegravir—Nervous system disorder—Zoledronate—osteoporosis	0.00106	0.00216	CcSEcCtD
Dolutegravir—Immune system disorder—Estradiol—osteoporosis	0.00106	0.00215	CcSEcCtD
Dolutegravir—Skin disorder—Zoledronate—osteoporosis	0.00105	0.00214	CcSEcCtD
Dolutegravir—Pruritus—Calcitriol—osteoporosis	0.00104	0.00213	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00104	0.00212	CcSEcCtD
Dolutegravir—Diarrhoea—Raloxifene—osteoporosis	0.00104	0.00212	CcSEcCtD
Dolutegravir—Dizziness—Estropipate—osteoporosis	0.00104	0.00212	CcSEcCtD
Dolutegravir—Diarrhoea—Ibandronate—osteoporosis	0.00103	0.0021	CcSEcCtD
Dolutegravir—Mental disorder—Estradiol—osteoporosis	0.00103	0.00209	CcSEcCtD
Dolutegravir—Dizziness—Alendronate—osteoporosis	0.00102	0.00209	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00102	0.00208	CcSEcCtD
Dolutegravir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00102	0.00208	CcSEcCtD
Dolutegravir—Fatigue—Pamidronate—osteoporosis	0.00102	0.00208	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Risedronate—osteoporosis	0.00102	0.00207	CcSEcCtD
Dolutegravir—Diarrhoea—Calcitriol—osteoporosis	0.00101	0.00206	CcSEcCtD
Dolutegravir—Skin disorder—Conjugated Estrogens—osteoporosis	0.00101	0.00206	CcSEcCtD
Dolutegravir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00101	0.00205	CcSEcCtD
Dolutegravir—Dizziness—Raloxifene—osteoporosis	0.00101	0.00205	CcSEcCtD
Dolutegravir—Flatulence—Estradiol—osteoporosis	0.001	0.00205	CcSEcCtD
Dolutegravir—Vomiting—Estropipate—osteoporosis	0.001	0.00204	CcSEcCtD
Dolutegravir—Dizziness—Ibandronate—osteoporosis	0.000997	0.00203	CcSEcCtD
Dolutegravir—Rash—Estropipate—osteoporosis	0.000991	0.00202	CcSEcCtD
Dolutegravir—Dermatitis—Estropipate—osteoporosis	0.000991	0.00202	CcSEcCtD
Dolutegravir—Headache—Estropipate—osteoporosis	0.000985	0.00201	CcSEcCtD
Dolutegravir—Vomiting—Alendronate—osteoporosis	0.000985	0.00201	CcSEcCtD
Dolutegravir—Abdominal pain—Risedronate—osteoporosis	0.000982	0.002	CcSEcCtD
Dolutegravir—Rash—Alendronate—osteoporosis	0.000977	0.00199	CcSEcCtD
Dolutegravir—Insomnia—Zoledronate—osteoporosis	0.000976	0.00199	CcSEcCtD
Dolutegravir—Dermatitis—Alendronate—osteoporosis	0.000976	0.00199	CcSEcCtD
Dolutegravir—Headache—Alendronate—osteoporosis	0.00097	0.00198	CcSEcCtD
Dolutegravir—Vomiting—Raloxifene—osteoporosis	0.000968	0.00197	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000966	0.00197	CcSEcCtD
Dolutegravir—Rash—Raloxifene—osteoporosis	0.00096	0.00196	CcSEcCtD
Dolutegravir—Dermatitis—Raloxifene—osteoporosis	0.00096	0.00195	CcSEcCtD
Dolutegravir—Vomiting—Ibandronate—osteoporosis	0.000959	0.00195	CcSEcCtD
Dolutegravir—Headache—Raloxifene—osteoporosis	0.000954	0.00194	CcSEcCtD
Dolutegravir—Rash—Ibandronate—osteoporosis	0.000951	0.00194	CcSEcCtD
Dolutegravir—Dermatitis—Ibandronate—osteoporosis	0.00095	0.00194	CcSEcCtD
Dolutegravir—Headache—Ibandronate—osteoporosis	0.000945	0.00192	CcSEcCtD
Dolutegravir—Insomnia—Conjugated Estrogens—osteoporosis	0.00094	0.00191	CcSEcCtD
Dolutegravir—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000939	0.00191	CcSEcCtD
Dolutegravir—Vomiting—Calcitriol—osteoporosis	0.000939	0.00191	CcSEcCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—MYC—osteoporosis	0.000936	0.022	CbGpPWpGaD
Dolutegravir—Nausea—Estropipate—osteoporosis	0.000934	0.0019	CcSEcCtD
Dolutegravir—Abdominal pain—Pamidronate—osteoporosis	0.000934	0.0019	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000932	0.0019	CcSEcCtD
Dolutegravir—Rash—Calcitriol—osteoporosis	0.000931	0.0019	CcSEcCtD
Dolutegravir—Fatigue—Zoledronate—osteoporosis	0.00093	0.0019	CcSEcCtD
Dolutegravir—Dermatitis—Calcitriol—osteoporosis	0.00093	0.00189	CcSEcCtD
Dolutegravir—Headache—Calcitriol—osteoporosis	0.000925	0.00188	CcSEcCtD
Dolutegravir—Nausea—Alendronate—osteoporosis	0.00092	0.00187	CcSEcCtD
Dolutegravir—Hypersensitivity—Risedronate—osteoporosis	0.000916	0.00187	CcSEcCtD
Dolutegravir—Vertigo—Estradiol—osteoporosis	0.000915	0.00187	CcSEcCtD
Dolutegravir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000914	0.00186	CcSEcCtD
Dolutegravir—Nausea—Raloxifene—osteoporosis	0.000905	0.00184	CcSEcCtD
Dolutegravir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000902	0.00184	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000897	0.00183	CcSEcCtD
Dolutegravir—Fatigue—Conjugated Estrogens—osteoporosis	0.000896	0.00183	CcSEcCtD
Dolutegravir—Nausea—Ibandronate—osteoporosis	0.000896	0.00182	CcSEcCtD
Dolutegravir—Asthenia—Risedronate—osteoporosis	0.000892	0.00182	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000882	0.0018	CcSEcCtD
Dolutegravir—Pruritus—Risedronate—osteoporosis	0.000879	0.00179	CcSEcCtD
Dolutegravir—Nausea—Calcitriol—osteoporosis	0.000877	0.00179	CcSEcCtD
Dolutegravir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000872	0.00178	CcSEcCtD
Dolutegravir—Hypersensitivity—Pamidronate—osteoporosis	0.00087	0.00177	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000861	0.00176	CcSEcCtD
Dolutegravir—Abdominal pain—Zoledronate—osteoporosis	0.000853	0.00174	CcSEcCtD
Dolutegravir—Diarrhoea—Risedronate—osteoporosis	0.00085	0.00173	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00085	0.00173	CcSEcCtD
Dolutegravir—Asthenia—Pamidronate—osteoporosis	0.000848	0.00173	CcSEcCtD
Dolutegravir—Dizziness—Ethinyl Estradiol—osteoporosis	0.000843	0.00172	CcSEcCtD
Dolutegravir—Pruritus—Pamidronate—osteoporosis	0.000836	0.0017	CcSEcCtD
Dolutegravir—Dizziness—Risedronate—osteoporosis	0.000822	0.00167	CcSEcCtD
Dolutegravir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000821	0.00167	CcSEcCtD
Dolutegravir—Nervous system disorder—Estradiol—osteoporosis	0.000816	0.00166	CcSEcCtD
Dolutegravir—Vomiting—Ethinyl Estradiol—osteoporosis	0.00081	0.00165	CcSEcCtD
Dolutegravir—Diarrhoea—Pamidronate—osteoporosis	0.000808	0.00165	CcSEcCtD
Dolutegravir—Skin disorder—Estradiol—osteoporosis	0.000808	0.00165	CcSEcCtD
Dolutegravir—Rash—Ethinyl Estradiol—osteoporosis	0.000804	0.00164	CcSEcCtD
Dolutegravir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000803	0.00164	CcSEcCtD
Dolutegravir—Headache—Ethinyl Estradiol—osteoporosis	0.000798	0.00163	CcSEcCtD
Dolutegravir—Hypersensitivity—Zoledronate—osteoporosis	0.000795	0.00162	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00079	0.0186	CbGpPWpGaD
Dolutegravir—Vomiting—Risedronate—osteoporosis	0.00079	0.00161	CcSEcCtD
Dolutegravir—Rash—Risedronate—osteoporosis	0.000784	0.0016	CcSEcCtD
Dolutegravir—Dermatitis—Risedronate—osteoporosis	0.000783	0.0016	CcSEcCtD
Dolutegravir—Dizziness—Pamidronate—osteoporosis	0.000781	0.00159	CcSEcCtD
Dolutegravir—Headache—Risedronate—osteoporosis	0.000779	0.00159	CcSEcCtD
Dolutegravir—Asthenia—Zoledronate—osteoporosis	0.000774	0.00158	CcSEcCtD
Dolutegravir—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000766	0.00156	CcSEcCtD
Dolutegravir—Pruritus—Zoledronate—osteoporosis	0.000763	0.00156	CcSEcCtD
Dolutegravir—Nausea—Ethinyl Estradiol—osteoporosis	0.000757	0.00154	CcSEcCtD
Dolutegravir—Insomnia—Estradiol—osteoporosis	0.000752	0.00153	CcSEcCtD
Dolutegravir—Vomiting—Pamidronate—osteoporosis	0.000751	0.00153	CcSEcCtD
Dolutegravir—Asthenia—Conjugated Estrogens—osteoporosis	0.000745	0.00152	CcSEcCtD
Dolutegravir—Rash—Pamidronate—osteoporosis	0.000745	0.00152	CcSEcCtD
Dolutegravir—Dermatitis—Pamidronate—osteoporosis	0.000744	0.00152	CcSEcCtD
Dolutegravir—Headache—Pamidronate—osteoporosis	0.00074	0.00151	CcSEcCtD
Dolutegravir—Diarrhoea—Zoledronate—osteoporosis	0.000738	0.0015	CcSEcCtD
Dolutegravir—Nausea—Risedronate—osteoporosis	0.000738	0.0015	CcSEcCtD
Dolutegravir—Pruritus—Conjugated Estrogens—osteoporosis	0.000735	0.0015	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000718	0.00146	CcSEcCtD
Dolutegravir—Fatigue—Estradiol—osteoporosis	0.000717	0.00146	CcSEcCtD
Dolutegravir—Dizziness—Zoledronate—osteoporosis	0.000714	0.00145	CcSEcCtD
Dolutegravir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000711	0.00145	CcSEcCtD
Dolutegravir—Nausea—Pamidronate—osteoporosis	0.000702	0.00143	CcSEcCtD
Dolutegravir—Dizziness—Conjugated Estrogens—osteoporosis	0.000687	0.0014	CcSEcCtD
Dolutegravir—Vomiting—Zoledronate—osteoporosis	0.000686	0.0014	CcSEcCtD
Dolutegravir—Rash—Zoledronate—osteoporosis	0.00068	0.00139	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Estradiol—osteoporosis	0.00068	0.00139	CcSEcCtD
Dolutegravir—Dermatitis—Zoledronate—osteoporosis	0.00068	0.00138	CcSEcCtD
Dolutegravir—Headache—Zoledronate—osteoporosis	0.000676	0.00138	CcSEcCtD
Dolutegravir—Vomiting—Conjugated Estrogens—osteoporosis	0.000661	0.00135	CcSEcCtD
Dolutegravir—Abdominal pain—Estradiol—osteoporosis	0.000657	0.00134	CcSEcCtD
Dolutegravir—Rash—Conjugated Estrogens—osteoporosis	0.000655	0.00133	CcSEcCtD
Dolutegravir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000655	0.00133	CcSEcCtD
Dolutegravir—Headache—Conjugated Estrogens—osteoporosis	0.000651	0.00133	CcSEcCtD
Dolutegravir—Nausea—Zoledronate—osteoporosis	0.000641	0.00131	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000638	0.015	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP27A1—osteoporosis	0.000621	0.0146	CbGpPWpGaD
Dolutegravir—Nausea—Conjugated Estrogens—osteoporosis	0.000617	0.00126	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000613	0.0144	CbGpPWpGaD
Dolutegravir—Hypersensitivity—Estradiol—osteoporosis	0.000613	0.00125	CcSEcCtD
Dolutegravir—Asthenia—Estradiol—osteoporosis	0.000597	0.00122	CcSEcCtD
Dolutegravir—Pruritus—Estradiol—osteoporosis	0.000588	0.0012	CcSEcCtD
Dolutegravir—Diarrhoea—Estradiol—osteoporosis	0.000569	0.00116	CcSEcCtD
Dolutegravir—Dizziness—Estradiol—osteoporosis	0.00055	0.00112	CcSEcCtD
Dolutegravir—Vomiting—Estradiol—osteoporosis	0.000529	0.00108	CcSEcCtD
Dolutegravir—Rash—Estradiol—osteoporosis	0.000524	0.00107	CcSEcCtD
Dolutegravir—Dermatitis—Estradiol—osteoporosis	0.000524	0.00107	CcSEcCtD
Dolutegravir—Headache—Estradiol—osteoporosis	0.000521	0.00106	CcSEcCtD
Dolutegravir—Nausea—Estradiol—osteoporosis	0.000494	0.00101	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000418	0.00984	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP19A1—osteoporosis	0.000326	0.00768	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000325	0.00765	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000322	0.00758	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—AGER—osteoporosis	0.000305	0.00718	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000303	0.00714	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—POMC—osteoporosis	0.000196	0.00462	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PKM—osteoporosis	0.000185	0.00435	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—FDPS—osteoporosis	0.000185	0.00435	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PGLS—osteoporosis	0.000175	0.00413	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPD2—osteoporosis	0.000175	0.00413	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ATIC—osteoporosis	0.00016	0.00377	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PNP—osteoporosis	0.00016	0.00377	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—OXCT1—osteoporosis	0.000136	0.00321	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CA2—osteoporosis	0.000136	0.00321	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MGLL—osteoporosis	0.000133	0.00313	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	0.000129	0.00303	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—IDH2—osteoporosis	0.000113	0.00266	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP27A1—osteoporosis	0.000106	0.0025	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACP5—osteoporosis	0.000103	0.00243	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—TPI1—osteoporosis	9.61e-05	0.00226	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—P4HB—osteoporosis	9.03e-05	0.00213	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GAPDH—osteoporosis	8.87e-05	0.00209	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—RAP1A—osteoporosis	8.64e-05	0.00203	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ENO1—osteoporosis	6.98e-05	0.00164	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PSMA2—osteoporosis	6.88e-05	0.00162	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PSMA5—osteoporosis	6.88e-05	0.00162	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP19A1—osteoporosis	5.58e-05	0.00131	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADCY5—osteoporosis	4.56e-05	0.00107	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPX1—osteoporosis	4.54e-05	0.00107	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTHFR—osteoporosis	4.19e-05	0.000987	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—POMC—osteoporosis	3.35e-05	0.000789	CbGpPWpGaD
